Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 505 to 507 of 507 entries
Sorted by: Best Match Show Resources per page
Transformation of organic micropollutants along hyporheic flow in bedforms of river-simulating flumes.

Scientific reports

Jaeger A, Posselt M, Schaper JL, Betterle A, Rutere C, Coll C, Mechelke J, Raza M, Meinikmann K, Portmann A, Blaen PJ, Horn MA, Krause S, Lewandowski J.
PMID: 34158517
Sci Rep. 2021 Jun 22;11(1):13034. doi: 10.1038/s41598-021-91519-2.

Urban streams receive increasing loads of organic micropollutants from treated wastewaters. A comprehensive understanding of the in-stream fate of micropollutants is thus of high interest for water quality management. Bedforms induce pumping effects considerably contributing to whole stream hyporheic...

Cite
Jaeger A, Posselt M, Schaper JL, et al. Transformation of organic micropollutants along hyporheic flow in bedforms of river-simulating flumes. Sci Rep. 2021;11(1):13034doi: 10.1038/s41598-021-91519-2.
Jaeger, A., Posselt, M., Schaper, J. L., Betterle, A., Rutere, C., Coll, C., Mechelke, J., Raza, M., Meinikmann, K., Portmann, A., Blaen, P. J., Horn, M. A., Krause, S., & Lewandowski, J. (2021). Transformation of organic micropollutants along hyporheic flow in bedforms of river-simulating flumes. Scientific reports, 11(1), 13034. https://doi.org/10.1038/s41598-021-91519-2
Jaeger, Anna, et al. "Transformation of organic micropollutants along hyporheic flow in bedforms of river-simulating flumes." Scientific reports vol. 11,1 (2021): 13034. doi: https://doi.org/10.1038/s41598-021-91519-2
Jaeger A, Posselt M, Schaper JL, Betterle A, Rutere C, Coll C, Mechelke J, Raza M, Meinikmann K, Portmann A, Blaen PJ, Horn MA, Krause S, Lewandowski J. Transformation of organic micropollutants along hyporheic flow in bedforms of river-simulating flumes. Sci Rep. 2021 Jun 22;11(1):13034. doi: 10.1038/s41598-021-91519-2. PMID: 34158517; PMCID: PMC8219703.
Copy Download .nbib Format: NLM
Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.

Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia

Taborsky M, Aiglova R, Lazarova M, Pavlu L, Danek J, Precek J, Schee A, Gloger V, Vicha M, Skala T.
PMID: 33325457
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Nov;165(4):402-407. doi: 10.5507/bp.2020.057. Epub 2020 Dec 15.

AIMS: Sub-analysis of a retrospective nation-wide observational analysis of heart failure (HF) epidemiology reported to the Czech National Registry of Reimbursed Health Services between 2012 and 2018 aimed at beta-blockers (BBs) utilization.METHODS AND RESULTS: The beta-blockers were generally used...

Cite
Taborsky M, Aiglova R, Lazarova M, et al. Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020;165(4):402-407doi: 10.5507/bp.2020.057.
Taborsky, M., Aiglova, R., Lazarova, M., Pavlu, L., Danek, J., Precek, J., Schee, A., Gloger, V., Vicha, M., & Skala, T. (2021). Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 165(4), 402-407. https://doi.org/10.5507/bp.2020.057
Taborsky, Milos, et al. "Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic." Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia vol. 165,4 (2021): 402-407. doi: https://doi.org/10.5507/bp.2020.057
Taborsky M, Aiglova R, Lazarova M, Pavlu L, Danek J, Precek J, Schee A, Gloger V, Vicha M, Skala T. Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2021 Nov;165(4):402-407. doi: 10.5507/bp.2020.057. Epub 2020 Dec 15. PMID: 33325457.
Copy Download .nbib Format: NLM
A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium.

Cureus

Olagunju A, Khatib M, Palermo-Alvarado F.
PMID: 33777573
Cureus. 2021 Feb 22;13(2):e13486. doi: 10.7759/cureus.13486.

According to the ARISTOTLE trial, apixaban was superior to warfarin because it was associated with fewer strokes, systemic embolism, and bleeding. Hemopericardium was one of the major bleeding events reported in this trial. However, the percentage of patients that...

Cite
Olagunju A, Khatib M, Palermo-Alvarado F. A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium. Cureus. 2021;13(2):e13486doi: 10.7759/cureus.13486.
Olagunju, A., Khatib, M., & Palermo-Alvarado, F. (2021). A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium. Cureus, 13(2), e13486. https://doi.org/10.7759/cureus.13486
Olagunju, Abdulbaril, et al. "A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium." Cureus vol. 13,2 (2021): e13486. doi: https://doi.org/10.7759/cureus.13486
Olagunju A, Khatib M, Palermo-Alvarado F. A Possible Drug-Drug Interaction Between Eliquis and Amiodarone Resulting in Hemopericardium. Cureus. 2021 Feb 22;13(2):e13486. doi: 10.7759/cureus.13486. PMID: 33777573; PMCID: PMC7990001.
Copy Download .nbib Format: NLM
Showing 505 to 507 of 507 entries